Shares of Cohance Lifesciences surged 5.5% to Rs 935 in intraday trade after Jefferies initiated coverage with a ‘Buy’ rating and a target price of Rs 1,150. The global brokerage…
Shares of pharmaceutical companies rallied up to 4% on Tuesday as investors expect that US President Donald Trump's executive order will have minimal impact on US generics. Dr Reddy's shares…
Aurobindo Pharma, part of the pharma space, has rallied more than 100% in FY24 but found some resistance above Rs 1,100 levels in January 2024.The stock underwent price wise correction…
After the IT sector it was the pharmaceutical sector which came into limelight as another big exporter from India. The valuations exploded and for a decade, pharma stocks were big…
Trideep Bhattacharya, CIO, Edelweiss MF, says: “It will probably take the next year for that improvement to come through. But the valuations over the next one or two quarters would…
Abhishek Basumallick, Chief Investment Adviser, Intelsense Capital, says “the problem with IT, especially IT services, is that until and unless there is very clear visibility of growth in the US…
" I think there is a longer-term challenge to the business. Near-term, of course, the deal gains have been fairly robust. So this year is going to be definitely a…
"Several infrastructure stocks where order books are almost 3x last year's sales, and there are some of them which are even 3.5, 3.7 times their last year’s sale so there…
, part of the pharma sector, gave a breakout from an inverse head & shoulder pattern on the weekly charts which suggests the beginning of a new trend that could…
Lupin, part of the pharma industry, is down more than 30 per cent from its September 2021 highs and a breakdown from the consolidation pattern in August further strengthens the…